Flowers Foods

Flowers Foods reported second-quarter results below expectations as fresh packaged bread demand weakened due to household budget constraints, shifting consumer preferences and competition. Management expects a year-over-year decline in Q3 with stabilization in Q4, citing significant new business wins, further cost reductions and an expanding innovation pipeline. The company is relaunching Nature's Own, expanding Dave's Killer Bread offerings (including sourdough), and introducing smaller-format, protein and fiber products to address portfolio gaps. Flowers forecasts roughly $20 million in additional cost benefits entering 2027 and continues productivity initiatives across bakeries and distribution. » Plus sur finance.yahoo.com

Flowers Foods reported adjusted earnings of $0.21 per share for Q2 2026 (expectation $0.24) and revenue of $1.19 billion (expectation $1.24 billion), with volume down 5.8% and sales down 4%. Adjusted EBITDA fell 19% to $111 million, and margins were hurt by weaker demand in the fresh-packaged bread segment and higher costs. The company lowered its full-year guidance for revenue, EBITDA and adjusted EPS and announced a cost-reduction program. The stock fell sharply after the results and is trading near its 52-week low. » Plus sur de.investing.com

Flowers Foods reduced its dividend as part of efforts to shore up its balance sheet after steep share declines; the stock closed at $7.14 on Aug. 10 and is down 56.29% over the past 52 weeks. JB Global Capital highlighted Flowers as a top position, calling the packaged-bakery business defensive and potentially undervalued with a sum-of-the-parts fair value estimate of $13–14. Hedge fund holdings in Flowers rose slightly to 34 portfolios at quarter-end, though some analysts remain bearish versus other sectors such as AI. » Plus sur finance.yahoo.com